Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zileuton and Celecoxib in Smokers
NCT01021215Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zileuton extended release in Lung disease, sponsored by National Cancer Institute. Started May 2010; status: completed.
02
Drugs
zileuton extended release
03
Conditions
Lung disease
Beyond the preview
Go deeper on NCT01021215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01021215.